| Title |
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
|
|---|---|
| Published in |
Trials, August 2020
|
| DOI | 10.1186/s13063-020-04616-4 |
| Pubmed ID | |
| Authors |
Javed Akram, Shehnoor Azhar, Muhammad Shahzad, Waqas Latif, Khalid Saeed Khan |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 278 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 278 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 40 | 14% |
| Student > Master | 24 | 9% |
| Student > Ph. D. Student | 21 | 8% |
| Other | 18 | 6% |
| Researcher | 16 | 6% |
| Other | 49 | 18% |
| Unknown | 110 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 76 | 27% |
| Nursing and Health Professions | 34 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 4% |
| Biochemistry, Genetics and Molecular Biology | 10 | 4% |
| Social Sciences | 7 | 3% |
| Other | 23 | 8% |
| Unknown | 117 | 42% |